Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-06-14

Clinical Trial Update: Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating fresh frozen plasma as a substitute for albumin in patients undergoing large volume paracentesis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Montefiore Medical Center | Conditions: Liver Cirrhosis, Ascites Hepatic | Phase 4 | Status: WITHDRAWN